Literature DB >> 33588864

A theoretical model of health management using data-driven decision-making: the future of precision medicine and health.

Eva Kriegova1, Milos Kudelka2, Martin Radvansky2, Jiri Gallo3,4.   

Abstract

BACKGROUND: The burden of chronic and societal diseases is affected by many risk factors that can change over time. The minimalisation of disease-associated risk factors may contribute to long-term health. Therefore, new data-driven health management should be used in clinical decision-making in order to minimise future individual risks of disease and adverse health effects.
METHODS: We aimed to develop a health trajectories (HT) management methodology based on electronic health records (EHR) and analysing overlapping groups of patients who share a similar risk of developing a particular disease or experiencing specific adverse health effects. Formal concept analysis (FCA) was applied to identify and visualise overlapping patient groups, as well as for decision-making. To demonstrate its capabilities, the theoretical model presented uses genuine data from a local total knee arthroplasty (TKA) register (a total of 1885 patients) and shows the influence of step by step changes in five lifestyle factors (BMI, smoking, activity, sports and long-distance walking) on the risk of early reoperation after TKA.
RESULTS: The theoretical model of HT management demonstrates the potential of using EHR data to make data-driven recommendations to support both patients' and physicians' decision-making. The model example developed from the TKA register acts as a clinical decision-making tool, built to show surgeons and patients the likelihood of early reoperation after TKA and how the likelihood changes when factors are modified. The presented data-driven tool suits an individualised approach to health management because it quantifies the impact of various combinations of factors on the early reoperation rate after TKA and shows alternative combinations of factors that may change the reoperation risk.
CONCLUSION: This theoretical model introduces future HT management as an understandable way of conceiving patients' futures with a view to positively (or negatively) changing their behaviour. The model's ability to influence beneficial health care decision-making to improve patient outcomes should be proved using various real-world data from EHR datasets.

Entities:  

Keywords:  Clinical decision-making tool; Early reoperation; Electronic health record; Formal concept analysis; Health trajectory; Lifestyle factors; Precision health; Precision medicine; Revision rate; Total knee arthroplasty

Mesh:

Year:  2021        PMID: 33588864      PMCID: PMC7885377          DOI: 10.1186/s12967-021-02714-8

Source DB:  PubMed          Journal:  J Transl Med        ISSN: 1479-5876            Impact factor:   5.531


  31 in total

1.  Lung cancer prevention.

Authors:  Christopher Slatore; Marianna Sockrider
Journal:  Am J Respir Crit Care Med       Date:  2014-11-15       Impact factor: 21.405

2.  Usefulness of the American Heart Association's Ideal Cardiovascular Health Measure to Predict Long-term Major Adverse Cardiovascular Events (From the Heart SCORE Study).

Authors:  Anh Thy H Nguyen; Anum Saeed; Claudia E Bambs; Justin Swanson; Nnadozie Emechebe; Fahad Mansuri; Karan Talreja; Steven E Reis; Kevin E Kip
Journal:  Am J Cardiol       Date:  2020-10-13       Impact factor: 2.778

Review 3.  Primary prevention of ischaemic heart disease: populations, individuals, and health professionals.

Authors:  Rajeev Gupta; David A Wood
Journal:  Lancet       Date:  2019-08-24       Impact factor: 79.321

Review 4.  Clinical Decision Support: a 25 Year Retrospective and a 25 Year Vision.

Authors:  B Middleton; D F Sittig; A Wright
Journal:  Yearb Med Inform       Date:  2016-08-02

5.  The value of patient activity level in the outcome of total hip arthroplasty.

Authors:  Paul E Beaulé; Frederic J Dorey; Ryan Hoke; Michel Le Duff; Harlan C Amstutz
Journal:  J Arthroplasty       Date:  2006-06       Impact factor: 4.757

Review 6.  Towards Prevention of Breast Cancer: What Are the Clinical Challenges?

Authors:  Signe Borgquist; Per Hall; Isaac Lipkus; Judy E Garber
Journal:  Cancer Prev Res (Phila)       Date:  2018-04-16

7.  Clinical Decision Support System for Evaluation of Patients with Musculoskeletal Disorders.

Authors:  Lecian C Lopes; Sayonara de Fátima F Barbosa
Journal:  Stud Health Technol Inform       Date:  2019-08-21

8.  Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.

Authors:  Salim Yusuf; Philip Joseph; Sumathy Rangarajan; Shofiqul Islam; Andrew Mente; Perry Hystad; Michael Brauer; Vellappillil Raman Kutty; Rajeev Gupta; Andreas Wielgosz; Khalid F AlHabib; Antonio Dans; Patricio Lopez-Jaramillo; Alvaro Avezum; Fernando Lanas; Aytekin Oguz; Iolanthe M Kruger; Rafael Diaz; Khalid Yusoff; Prem Mony; Jephat Chifamba; Karen Yeates; Roya Kelishadi; Afzalhussein Yusufali; Rasha Khatib; Omar Rahman; Katarzyna Zatonska; Romaina Iqbal; Li Wei; Hu Bo; Annika Rosengren; Manmeet Kaur; Viswanathan Mohan; Scott A Lear; Koon K Teo; Darryl Leong; Martin O'Donnell; Martin McKee; Gilles Dagenais
Journal:  Lancet       Date:  2019-09-03       Impact factor: 79.321

9.  Designing and piloting a generic research architecture and workflows to unlock German primary care data for secondary use.

Authors:  Thomas Bahls; Johannes Pung; Stephanie Heinemann; Johannes Hauswaldt; Iris Demmer; Arne Blumentritt; Henriette Rau; Johannes Drepper; Philipp Wieder; Roland Groh; Eva Hummers; Falk Schlegelmilch
Journal:  J Transl Med       Date:  2020-10-19       Impact factor: 5.531

10.  Identifying individuals with chronic pain after knee replacement: a population-cohort, cluster-analysis of Oxford knee scores in 128,145 patients from the English National Health Service.

Authors:  Rafael Pinedo-Villanueva; Sara Khalid; Vikki Wylde; Rachael Gooberman-Hill; Anushka Soni; Andrew Judge
Journal:  BMC Musculoskelet Disord       Date:  2018-10-02       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.